Walleye Capital’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Walleye Capital’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-16,870	Closed	-$2K	–	1672
2021 Q1	$2K	Buy	16,870 +8,417	+100%	+$996K	0.12%	146
2020 Q4	$998	Buy	+8,453	New	+$982K	0.07%	287
2020 Q2	–	Sell	-11,469	Closed	-$1.24M	–	1170
2020 Q1	$1.24M	Buy	+11,469	New	+$1.32M	0.27%	100
2019 Q4	–	Sell	-240	Closed	-$27.8K	–	2476
2019 Q3	$27K	Buy	+240	New	+$23.9K	﹤0.01%	1703

Walleye Capital's CBPO Position: Q2 2021 in Review

Walleye Capital sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 16,870 shares — an estimated $2K sold.

Walleye Capital first reported a position in CBPO in Q3 2019 and held it in 4 quarters. The position peaked at $1.24M in Q1 2020. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.

Walleye Capital reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
Walleye Capital sold 16,870 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $2K.
Walleye Capital first reported a position in China Biologic Products Holdings, Inc. in Q3 2019 and held it in 4 quarters.
Walleye Capital's China Biologic Products Holdings, Inc. position peaked at $1.24M in Q1 2020.
0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.

Based on Walleye Capital's 13F filing for Q2 2021, filed 16 Aug 2021.